PACLITAXEL ALBUMIN-BOUND, NIVOLUMAB, GEMCITABINE, IPILIMUMAB, SOTORASIB, ODM-212 5 mg coated tablet, ODM-212 40 mg coated tablet
3134003
Phase 2 small_molecule active
Quick answer
PACLITAXEL ALBUMIN-BOUND, NIVOLUMAB, GEMCITABINE, IPILIMUMAB, SOTORASIB, ODM-212 5 mg coated tablet, ODM-212 40 mg coated tablet for Neoplasms benign malignant and unspecified (incl. cysts and polyps) is a Phase 2 program (small_molecule) at Orion with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orion
- Indication
- Neoplasms benign malignant and unspecified (incl. cysts and polyps)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active